HomeCompareMNODF vs MRK

MNODF vs MRK: Dividend Comparison 2026

MNODF yields 2.91% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $14.1K in total portfolio value
10 years
MNODF
MNODF
● Live price
2.91%
Share price
$11.35
Annual div
$0.33
5Y div CAGR
26.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$42.7K
Annual income
$5,694.61
Full MNODF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — MNODF vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMNODFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MNODF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MNODF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MNODF
Annual income on $10K today (after 15% tax)
$247.06/yr
After 10yr DRIP, annual income (after tax)
$4,840.42/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $3,487.99/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MNODF + MRK for your $10,000?

MNODF: 50%MRK: 50%
100% MRK50/50100% MNODF
Portfolio after 10yr
$49.7K
Annual income
$7,746.37/yr
Blended yield
15.57%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

MNODF
No analyst data
Altman Z
3.2
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MNODF buys
0
MRK buys
0
No recent congressional trades found for MNODF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMNODFMRK
Forward yield2.91%2.76%
Annual dividend / share$0.33$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR26.4%32.7%
Portfolio after 10y$42.7K$56.8K
Annual income after 10y$5,694.61$9,798.13
Total dividends collected$19.5K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MNODF vs MRK ($10,000, DRIP)

YearMNODF PortfolioMNODF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,067$367.39$11,206$366.19$139.00MRK
2$12,322$480.33$12,650$502.35$328.00MRK
3$13,817$631.76$14,407$694.19$590.00MRK
4$15,621$836.81$16,585$967.82$964.00MRK
5$17,832$1,117.60$19,342$1,363.89$1.5KMRK
6$20,587$1,507.10$22,913$1,947.19$2.3KMRK
7$24,084$2,055.45$27,662$2,823.89$3.6KMRK
8$28,610$2,840.52$34,159$4,173.35$5.5KMRK
9$34,599$3,986.18$43,337$6,308.80$8.7KMRK
10$42,715$5,694.61$56,776$9,798.13$14.1KMRK

MNODF vs MRK: Complete Analysis 2026

MNODFStock

Mondi plc, together with its subsidiaries, engages in the manufacture and sale of packaging and paper solutions in Africa, Western Europe, Emerging Europe, Russia, North America, South America, Asia, and Australia. The company operates through three segments: Corrugated Packaging, Flexible Packaging, and Uncoated Fine Paper. The Corrugated Packaging segment provides virgin and recycled containerboards for fresh fruit packaging and heavy and fragile goods transport packaging applications; and corrugated solutions, such as corrugated boxes and packaging products. The Flexible Packaging segment offers sack kraft paper, paper bags, specialty kraft paper, consumer flexibles, and functional paper and films. The Uncoated Fine Paper segment provides uncoated fine paper, including home, office, converting, and professional printing papers; and market pulp. The company was incorporated in 2007 and is based in Weybridge, the United Kingdom.

Full MNODF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this MNODF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MNODF vs SCHDMNODF vs JEPIMNODF vs OMNODF vs KOMNODF vs MAINMNODF vs JNJMNODF vs ABBVMNODF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.